At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Vitamin D3, Cholecalciferol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Double-Blind Placebo-Controlled Pilot Study of Vitamin D Supplementation for the Treatment of Bipolar Depression
In Brief
A clinical study evaluating Vitamin D3, Cholecalciferol and Placebo for Bipolar Disorder and Bipolar Depression. Completed, enrolled 33 participants across 2 sites.
Detailed Summary
The purpose of this study is to whether vitamin d supplementation in those with low levels may reduce depression symptoms in people experiencing bipolar depression.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Bipolar Depression
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJun 2013
First PostedJun 2013
Primary CompletionAug 2015
TodayJul 2026
First PostedJun 24, 2013
Enrollment StartJun 1, 2013
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.0 years ago
Interventions
Vitamin D3, Cholecalciferoldrug
Placebodrug